Interleukin-18 and fibroblast growth factor 2 in combination is a useful diagnostic biomarker to distinguish adult-onset Still's disease from sepsis.
Koga T, Sumiyoshi R, Furukawa K, Sato S, Migita K, Shimizu T, Umeda M, Endo Y, Fukui S, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Nonaka F, Yachie A, Kondo H, Maeda T, Kawakami A.
Koga T, et al. Among authors: kondo h.
Arthritis Res Ther. 2020 May 7;22(1):108. doi: 10.1186/s13075-020-02200-4.
Arthritis Res Ther. 2020.
PMID: 32381117
Free PMC article.